NASDAQ
14.05.25 | 21:55
0,660 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | NeuroOne expects FY25 revenue to reach $8M-$10M as OneRF platform advances and new FDA submission broadens pipeline | 1 | Seeking Alpha | ||
| Di | NeuroOne Medical Technologies GAAP EPS of -$0.07 | 1 | Seeking Alpha | ||
| Di | NEUROONE MEDICAL TECHNOLOGIES Corp - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| Di | NeuroOne Medical Technologies Corporation: NeuroOne Reports Second Quarter Fiscal Year 2025 Financial Results; Gross Margin Improves Significantly YoY to 55.6% | 120 | GlobeNewswire (Europe) | Filed 510(k)Submission with FDA for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain Ahead of Schedule Company Fully Funded Through at Least Fiscal Year 2026 Following Oversubscribed $8.2... ► Artikel lesen | |
| Mo | NeuroOne appoints Parag Patil as chief medical advisor | 2 | Seeking Alpha | ||
| Mo | NeuroOne Medical Technologies Corporation: NeuroOne Appoints Renowned Neurosurgeon Dr. Parag Patil as Chief Medical Advisor | 287 | GlobeNewswire (Europe) | Significant Neurological Expertise to Help Drive Clinical Development Strategy and Growth with New Technologies EDEN PRAIRIE, Minn., May 12, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies... ► Artikel lesen | |
| NEUROONE MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| Fr | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 05.05. | D.Boral Capital: NeuroOne Medical Announces Participation in The D. Boral Capital Inaugural Global Conference | 267 | Newsfile | Eden Prairie, Minnesota--(Newsfile Corp. - May 5, 2025) - NeuroOne Medical (NASDAQ: NMTC), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14... ► Artikel lesen | |
| 01.05. | NeuroOne Medical Technologies Corporation: NeuroOne to Report Second Quarter Fiscal Year 2025 Financial Results on Tuesday, May 13 at 8:30 a.m. Eastern Time | 2 | GlobeNewswire (USA) | ||
| 23.04. | NeuroOne completes FDA submission for nerve ablation tech to treat facial pain | 1 | MassDevice | ||
| 23.04. | NeuroOne files early FDA 510(k) for nerve ablation system | 2 | Investing.com | ||
| 23.04. | NeuroOne Medical Technologies Corporation: NeuroOne Completes FDA Submission for the OneRF Trigeminal Nerve Ablation System to Treat Facial Pain | 80 | GlobeNewswire (Europe) | Multi-Contact Probe Provides Alternative to Pharmaceutical and Invasive Surgical Treatments Submission Completed Earlier Than Anticipated EDEN PRAIRIE, Minn., April 23, 2025 (GLOBE NEWSWIRE) -- NeuroOne... ► Artikel lesen | |
| 23.04. | EXCLUSIVE: NeuroOne Submits FDA Marketing Application For OneRF Trigeminal Nerve Ablation System For Facial Pain | 1 | Benzinga.com | ||
| 16.04. | NeuroOne says tariffs won't impact business, Zimmer Biomet deal | 5 | MassDevice | ||
| 16.04. | NeuroOne secures funding through fiscal 2026, unaffected by tariffs | 1 | Investing.com | ||
| 16.04. | NeuroOne sichert Finanzierung bis zum Geschäftsjahr 2026, bleibt von Zöllen unbeeinflusst | 2 | Investing.com Deutsch | ||
| 16.04. | NeuroOne Medical Technologies Corporation: NeuroOne Issues Letter to Shareholders | 163 | GlobeNewswire (Europe) | Company Now Fully Funded Through at least Fiscal 2026; Company Confirms No Material Impact from Global Tariffs EDEN PRAIRIE, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies... ► Artikel lesen | |
| 14.04. | NeuroOne Medical Technologies Corporation: NeuroOne OneRF Technology Success Story Featured on Fox News | 1 | GlobeNewswire (USA) | ||
| 07.04. | NEUROONE MEDICAL TECHNOLOGIES Corp - 8-K, Current Report | 1 | SEC Filings | ||
| 04.04. | Nasdaq Dips 5%; NeuroOne Medical Technologies Shares Plummet | 3 | Benzinga.com |
Seite:
1 2 3 Weiter >>
59 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| UNITEDHEALTH | 231,95 | -15,90 % | UnitedHealth Group-Aktie leicht im Minus (338,6583 €) | Im US-amerikanischen Wertpapierhandel liegt die Aktie der UnitedHealth Group gegenwärtig im Minus. Die Aktie notiert derzeit bei 381,59 US-Dollar. Die UnitedHealth Group-Aktie verzeichnet aktuell ein... ► Artikel lesen | |
| FRESENIUS | 42,390 | +1,48 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 45 auf 50 Euro angehoben und die Einstufung auf "Buy" belassen. Nach dem starken Jahresstart der Aktie hätten... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 48,500 | +0,73 % | GOLDMAN SACHS stuft Siemens Healthineers auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Siemens Healthineers von 60 auf 56 Euro gesenkt, aber die Einstufung auf "Neutral" belassen. Richard Felton passte... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 50,70 | +1,40 % | Fresenius Medical Care: Analysten pessimistisch - Die Kasse klingelt! | ||
| INCANNEX HEALTHCARE | 0,671 | 0,00 % | Incannex Healthcare Inc. - 10-Q, Quarterly Report | ||
| BRIGHTSPRING HEALTH SERVICES | 23,480 | 0,00 % | IPO Stock Of The Week: Health Care Leader BrightSpring Poised To Hit New Buy Point | ||
| ALIGNMENT HEALTHCARE | 14,910 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| NUTEX HEALTH | 158,61 | 0,00 % | Nutex Health, Inc.: Nutex Health Reports First Quarter 2025 Financial Results | TOTAL REVENUE OF $211.8 MILLION VERSUS $67.5 MILLION IN Q1 2024, AN INCREASE OF 213.8%
NET INCOME ATTRIBUTABLE TO NUTEX HEALTH INC. OF $14.6 MILLION VERSUS NET... ► Artikel lesen | |
| HIMS & HERS HEALTH | 55,04 | +0,51 % | Hims & Hers Stock Pulls Back After Strong Q1 Earnings, 115% Gain Over Past Month | ||
| GENEDX | 59,51 | 0,00 % | GeneDx Holdings stock trades higher as upgraded at Jefferies | ||
| PROCEPT BIOROBOTICS | 54,75 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| GERRESHEIMER | 61,75 | -0,24 % | EQS-News: Gerresheimer AG: Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab | EQS-News: Gerresheimer AG
/ Schlagwort(e): Sonstiges/Nachhaltigkeit
Gerresheimer schließt Investition in hochmoderne Glasproduktion am Standort Lohr erfolgreich ab
12.05.2025... ► Artikel lesen | |
| BASEL MEDICAL GROUP | 1,640 | 0,00 % | Basel Medical Group Ltd: Basel Medical Group Completes Acquisition of Bethesda Medical to Strengthen Healthcare Ecosystem in Singapore and Southeast Asia | Singapore, April 30, 2025 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL), today announced the closing of the acquisition of Bethesda Medical Pte. Ltd., a leading Singapore-based healthcare... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 5,820 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2025 Outlook | First Quarter Revenue was $559.2 million, a 14.0% increase over the prior year period Gross margin increased 25.9% to $183.6 million compared to Q1 2024 First Quarter Net income was $5.2 million compared... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 62,00 | +0,16 % | Ihre wichtigsten Termine: Alle Blicke auf: Boeing, Bayer, Carl Zeiss Meditec, Rheinmetall, Sixt & Jenoptik | © Foto: Bayer AGGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Unternehmenstermine 07:00 Uhr, Deutschland:... ► Artikel lesen |
Das Unternehmen NEUROONE MEDICAL TECHNOLOGIES CORPORATION kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,660 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEUROONE MEDICAL TECHNOLOGIES CORPORATION finden Sie auf Wallstreet Online.